MC1675A1 - Dérivés de dihydropyridine - Google Patents

Dérivés de dihydropyridine

Info

Publication number
MC1675A1
MC1675A1 MC851776A MC1776A MC1675A1 MC 1675 A1 MC1675 A1 MC 1675A1 MC 851776 A MC851776 A MC 851776A MC 1776 A MC1776 A MC 1776A MC 1675 A1 MC1675 A1 MC 1675A1
Authority
MC
Monaco
Prior art keywords
dihydropyridine derivatives
dihydropyridine
derivatives
Prior art date
Application number
MC851776A
Other languages
English (en)
French (fr)
Inventor
Roland Jaunin
Henri Ramuz
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MC1675A1 publication Critical patent/MC1675A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/021,2-Thiazines; Hydrogenated 1,2-thiazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Dental Preparations (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
MC851776A 1984-06-27 1985-06-25 Dérivés de dihydropyridine MC1675A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH309784 1984-06-27

Publications (1)

Publication Number Publication Date
MC1675A1 true MC1675A1 (fr) 1986-06-03

Family

ID=4248551

Family Applications (1)

Application Number Title Priority Date Filing Date
MC851776A MC1675A1 (fr) 1984-06-27 1985-06-25 Dérivés de dihydropyridine

Country Status (16)

Country Link
US (1) US4742069A (ja)
EP (1) EP0166422A1 (ja)
JP (1) JPS6118762A (ja)
CN (1) CN85105335A (ja)
AU (1) AU4399185A (ja)
DK (1) DK288085A (ja)
ES (2) ES8609253A1 (ja)
FI (1) FI852359L (ja)
GR (1) GR851554B (ja)
HU (1) HU193784B (ja)
IL (1) IL75595A0 (ja)
MC (1) MC1675A1 (ja)
NO (1) NO852576L (ja)
PH (1) PH21510A (ja)
PT (1) PT80719B (ja)
ZA (1) ZA854665B (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6541479B1 (en) * 1997-12-02 2003-04-01 Massachusetts College Of Pharmacy Calcium channel blockers
CN106011652B (zh) 2016-06-28 2017-12-26 宝山钢铁股份有限公司 一种磷化性能优异的冷轧低密度钢板及其制造方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2639498A1 (de) * 1976-09-02 1978-03-09 Bayer Ag Neue schwefelhaltige amino-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2658183A1 (de) * 1976-12-22 1978-07-06 Bayer Ag In 2-position substituierte 1,4- dihydropyridin-derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2747513A1 (de) * 1977-10-22 1979-05-03 Bayer Ag Dihydropyridine mit schwefelhaltigen estergruppierungen
SE429652B (sv) * 1978-06-30 1983-09-19 Haessle Ab 2.6-dimetyl-4-(2.3-diklorfenyl)-1.4-dihydropyridin-3.5-dikarboxylsyra-3-metylester-5-etylester
DE3116129A1 (de) * 1981-04-23 1982-11-11 Hoechst Ag, 6000 Frankfurt 2-ketosulfonamide und verfahren zu ihrer herstellung
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines

Also Published As

Publication number Publication date
IL75595A0 (en) 1985-10-31
PT80719A (en) 1985-07-01
DK288085D0 (da) 1985-06-25
FI852359L (fi) 1985-12-28
ZA854665B (en) 1986-02-26
FI852359A0 (fi) 1985-06-13
HU193784B (en) 1987-11-30
HUT37923A (en) 1986-03-28
NO852576L (no) 1985-12-30
ES8609253A1 (es) 1986-09-01
AU4399185A (en) 1986-01-02
PT80719B (en) 1987-04-23
ES8705388A1 (es) 1987-05-01
US4742069A (en) 1988-05-03
DK288085A (da) 1985-12-28
PH21510A (en) 1987-11-10
CN85105335A (zh) 1987-01-14
GR851554B (ja) 1985-11-25
JPS6118762A (ja) 1986-01-27
ES551817A0 (es) 1987-05-01
ES544558A0 (es) 1986-09-01
EP0166422A1 (de) 1986-01-02

Similar Documents

Publication Publication Date Title
DK268285A (da) Dialkoxypyridinderivater
DK35785D0 (da) Tetrahydrocarbazolonderivater
DK243985A (da) Aminoalkylphenoxyderivater
DE3463503D1 (de) Sulfonamido-benzamide derivatives
DE3566887D1 (de) Flavanon derivatives
DK524585D0 (da) Cholecalciferolderivater
DK501085D0 (da) Substituerede benzimidazolderivater
DK443685A (da) Pirimidinderivater
DK460785D0 (da) Substituerede furanylderivater
DK300887D0 (da) Dihydropyridinderivater
ES543349A0 (es) Preparado solido de dihidropiridina
DK320585D0 (da) Fluorallylaminderivater
DK15686A (da) Dihydropyridinderivater
ES539508A0 (es) Derivados de androsteno nuevos
DK64286A (da) Dihydropyridinderivater
DK514585D0 (da) Aminoethylanilinderivater
DE3565100D1 (de) Cycloalkane-indene-carboximidamide derivatives
DK267190D0 (da) 13-substitueret-5-ketomilbemycinderivater
DK224786D0 (da) Dihydropyridinderivater
MC1675A1 (fr) Dérivés de dihydropyridine
DK54085A (da) Phenylpropargylaminderivater
ES539375A0 (es) Derivados de alquilidenimidazol sustituidos
DE3564269D1 (de) Eburnane derivatives
MA20389A1 (fr) Derives de thiatriazines
DK569185A (da) 1,4-dihydropyridinderivater

Legal Events

Date Code Title Description
YP Annual fee paid